OPN1MW and Alzheimer disease: Nevertheless, these findings underscore the potential for CBD to play a more expansive role in the development of AD treatments and excited possibilities for CBD analogs as drug candidates to improve binding interactions and stability with AD-associated protein targets through various analyses.